Delivery Order SPE2DB24D9222-SPE2DB25FAZKA
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $4.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,868.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 4, 2025. This firm fixed-price delivery order covers the supply of Xtandi 40 mg capsules (120-count units), an oncology medication used in prostate cancer treatment. The contract carries no set-aside designation and is scheduled for ultimate completion by September 5, 2025, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count). This firm fixed-price delivery order, issued on July 22, 2025, is expected to be completed by July 23, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, was awarded without set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open...
- On July 28, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4568915549, covers the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in the treatment of prostate cancer. This firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance to take place...
- The Defense Logistics Agency (DLA) awarded a $4,311.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,683.02 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count units), an oncology medication used in cancer treatment, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, allowing the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $12,508.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which does not have a set-aside designation, is for the delivery of Xtandi 40 mg tablets (120 count) and is a firm fixed-price order. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units). This firm fixed-price delivery order, issued on July 1, 2025, with an ultimate completion date of July 2, 2025, represents a time-sensitive pharmaceutical supply requirement. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $4,169.59 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of Xtandi 40 mg tablets, a prescription medication used in the treatment of prostate cancer. The delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle valued at $499,999,999 and valid through November 2026, which allows the DLA to issue firm fixed-price...